Indaptus Therapeutics, Inc. - Common Stock, Par Value $0.01 Per Share (INDP) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2021 to Q2 2025

Type / Class
Equity / Common Stock, Par Value $0.01 Per Share
Symbol
INDP on Nasdaq
Shares outstanding
2,139,852
Price per share
$0.46
Price from insider filings
$0.46
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Indaptus Therapeutics, Inc. - Common Stock, Par Value $0.01 Per Share (INDP) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
YA II PN, Ltd. 10% $705,458 1,410,916 YA II PN, Ltd. 13 Feb 2025
Meckler Jeffrey A 13% $125,627 273,103 Jeffery A. Meckler 22 Dec 2025
Newman Michael James 5.4% $53,154 115,552 Newman Michael James 22 Dec 2025

Institutional Holders of Indaptus Therapeutics, Inc. - Common Stock, Par Value $0.01 Per Share (INDP) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q2 0 $0 -$353,682 $0.46 0
2025 Q1 643,262 $353,682 +$16,672 $0.55 17
2024 Q4 638,409 $539,564 +$18,707 $0.84 19
2024 Q3 605,020 $750,238 +$5,985 $1.24 17
2024 Q2 599,915 $1,262,320 +$23,925 $2.12 21
2024 Q1 587,768 $1,314,120 -$24,471 $2.24 17
2023 Q4 602,239 $1,058,915 +$56,020 $1.76 18
2023 Q3 570,529 $1,569,014 -$25,658 $2.76 16
2023 Q2 583,740 $1,109,616 +$8,428 $1.91 15
2023 Q1 579,339 $1,079,449 -$60,057 $1.85 15
2022 Q4 576,419 $838,524 +$5,682 $1.45 16
2022 Q3 566,356 $1,222,000 +$141,749 $2.17 12
2022 Q2 500,710 $1,306,000 -$3,185,888 $2.61 12
2022 Q1 1,687,829 $6,751,000 -$661,036 $4.00 9
2021 Q4 1,836,196 $10,466,000 +$6,508,484 $5.70 11
2021 Q3 541,295 $4,239,000 +$4,239,000 $7.83 9